These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14974371)

  • 1. [Non-traditional atherosclerosis risk factors in patients with renal artery stenosis and hypertension].
    Berent H; Kuczyńska K; Wocial B; Dutkiewicz-Raczkowska M; Symonides B
    Pol Merkur Lekarski; 2003 Oct; 15(88):380-1; discussion 381-2. PubMed ID: 14974371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm.
    Sofi F; Marcucci R; Giusti B; Pratesi G; Lari B; Sestini I; Lo Sapio P; Pulli R; Pratesi C; Abbate R; Gensini GF
    Thromb Haemost; 2005 Nov; 94(5):1094-8. PubMed ID: 16363254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A; Galar M
    Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.
    Chade AR; Rodriguez-Porcel M; Grande JP; Zhu X; Sica V; Napoli C; Sawamura T; Textor SC; Lerman A; Lerman LO
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1295-301. PubMed ID: 12750121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors.
    Paraskevas KI; Hamilton G; Cross JM; Mikhailidis DP
    Nephron Clin Pract; 2008; 108(1):c56-66. PubMed ID: 18097149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
    de Silva R; Nikitin NP; Bhandari S; Nicholson A; Clark AL; Cleland JG
    Eur Heart J; 2005 Aug; 26(16):1596-605. PubMed ID: 15919719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The profile of cardiac patients with renal artery stenosis.
    Buller CE; Nogareda JG; Ramanathan K; Ricci DR; Djurdjev O; Tinckam KJ; Penn IM; Fox RS; Stevens LA; Duncan JA; Levin A
    J Am Coll Cardiol; 2004 May; 43(9):1606-13. PubMed ID: 15120819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural history of renal artery stenosis].
    Azizi M
    Rev Prat; 1996 May; 46(9):1084-90. PubMed ID: 8763014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renovascular hypertension: diagnostic and therapeutic challenges.
    Bosmans JL; De Broe ME
    JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
    Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal artery stenosis and accelerated atherosclerosis: which comes first?
    Fava C; Minuz P; Patrignani P; Morganti A
    J Hypertens; 2006 Sep; 24(9):1687-96. PubMed ID: 16915013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic nephropathy: can we preserve renal function?
    Vidt DG
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S70-3. PubMed ID: 11986899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.